TEVA · NYSE · Drug Manufacturers - Specialty & Generic

Teva (ADR)

Combines global generics scale with innovative neuroscience and immunology medicines.

$36.30
After-hours close−0.13 (−0.36%)
At close$36.43(−3.16%)

Breakdown13F · Form 4

Institutions 66.79%777.89M sharesInsiders 0.46%5.38M sharesOther 32.75%381.37M shares

Shares outstanding 1.16B · Float 1.16B · 100.0% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
BlackRock, Inc.63.89M5.49%13FAug 7, 2026
Harel Insurance Investments & Financial Services Ltd.48.14M4.13%13FJul 29, 2026
Phoenix Holdings Ltd.42.93M3.69%13FAug 11, 2026
WCM Investment Management, LLC41.32M3.55%13FAug 13, 2026
Clal Insurance Enterprises Holdings Ltd40.60M3.49%13FAug 13, 2026

Institutions13F, as of Jun 30, 2026

712 holders · 777.89M shares · 85 new positions · 362 increased · 193 reduced · 64 closed

HolderShares% outstandingChg q/qFiled
BlackRock, Inc.63.89M5.49%−1.24MAug 7, 2026
Harel Insurance Investments & Financial Services Ltd.48.14M4.13%+2.18MJul 29, 2026
Phoenix Holdings Ltd.42.93M3.69%+156.0KAug 11, 2026
WCM Investment Management, LLC41.32M3.55%+494.6KAug 13, 2026
Clal Insurance Enterprises Holdings Ltd40.60M3.49%+2.15MAug 13, 2026
Menora Mivtachim Holdings Ltd.39.85M3.42%+228.0KAug 13, 2026
Migdal Insurance & Financial Holdings Ltd.38.92M3.34%+1.02MAug 10, 2026
Norges Bank32.30M2.77%+32.30MnewAug 12, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Harel Insurance Investments & Financial Services Ltd6.30%72.33M13GFeb 9, 2026
Migdal Insurance & Financial Holdings Ltd5.37%61.69M13GFeb 17, 2026
Phoenix Financial Ltd.5.00%57.38M13GJul 22, 2025
Menora Mivtachim Holdings Ltd5.00%57.40M13GJul 17, 2025

InsidersForm 4

InsiderRoleShares% outstandingFiled
Amir Elsteindirector2.12M0.18%Jun 8, 2026
Richard D. Francisofficer: President and CEO1.18M0.10%Jun 8, 2026
Roberto Mignonedirector487.4K0.04%Jun 8, 2026
Sol J. Barerdirector448.0K0.04%Jun 8, 2026
Eric A. Hughesofficer: See "Remarks"134.9K0.01%Aug 5, 2026
Gerald M. Liebermandirector130.1K0.01%Jun 8, 2026
Rosemary A. Cranedirector127.7K0.01%Jun 8, 2026
Perry Nisendirector119.8K0.01%Jun 8, 2026
Ronit Satchi-Fainarodirector112.0K0.01%Aug 25, 2026
Mark Sabagofficer: See "Remarks"80.8K0.01%May 4, 2026

1 ten-percent owner holds 3.00M shares by Form 4, outside the officers-and-directors figure above · 16 people have not refiled in the last 18 months (2.53M shares), so they are not in the figure above

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Aug 21, 2026
Amir Weissofficer: Chief Accounting Officer
Sale · 2 lots9,445$37.6213,071
Aug 21, 2026
Ronit Satchi-Fainarodirector
Sale415$37.25111,986
Aug 17, 2026
Evan Lippmanofficer: EVP, Business Development
Sale18,600$36.5725,591
Aug 5, 2026
Tal Zvi Zaksdirector
Sale17$34.8773,247
Aug 3, 2026
Eric A. Hughesofficer: See "Remarks"
Sale25,578$34.88134,877
Aug 3, 2026
Placid Joverofficer: See "Remarks"
Sale12,827$34.886,774
Jun 18, 2026
Matthew Shieldsofficer: EVP, Global Operations
Sale9,989$32.190
Jun 11, 2026
Eliyahu Sharon Kalifofficer: EVP, Chief Financial Officer
Sale106,563$34.1065,621
Jun 5, 2026
Richard D. Francisofficer: President and CEO
Sale6,153$34.351,177,529
Jun 3, 2026
Matthew Shieldsofficer: EVP, Global Operations
Sale16,195$32.879,989

CongressHouse and Senate disclosures

Not reported.